Prof. F. Fazekas, President of the EAN and Prof. Z. Katsarava President of the European Headache Federation (EHF) are pleased to announce that:
EAN has joined with EHF to promote optimal management of headache disorders care in Europe.
EAN and… Continue Reading
Get a glimpse of the key highlights, insights, and standout moments from EAN 2025 in Helsinki, all captured in our Congress Review eBook.
Latest Posts
-
-
The European Brain Council (EBC) recently provided feedback to the European Commission on the Horizon Europe proposals that were published in June 2018.
-
EFNAOther News
Patient Advocacy in the Digital World – Registration now open for EFNA’s young advocates workshop
September 1, 2018WHEN: November 19 – 21, 2018
WHERE: Brussels, Begium
WHO: Anyone between the ages of 18 and 35, living in Europe, who is affected by a neurological disorder
The workshop will take place through the English language. A good level… Continue Reading -
Other NewsTop Articles
23rd World Congress of the International Association of Parkinson’s Disease and Related Disorders (IAPRD)
September 1, 2018The XXIII World Congress of the International Association of Parkinson’s Disease and Related Disorders (IAPRD) was held from August 19th to 22th, 2018, in Lyon, France, at the Lyon Convention Centre, a beautiful location designed by the famous Italian… Continue Reading
-
In August we uploaded a new webinar to ebrain, a round table discussion, by experts, Professors Werner Poewe, Angelo Antonini and Oliver Rascol on “Is Delaying Levodopa a Disservice to Patients?” The discussion centres around how to recognize when levodopa… Continue Reading
-
Education cornerEducation
8th European Teaching Course on Neurorehabilitation – Brain Days
September 1, 2018This event was organized by the Foundation of the Society for the Study of Neuroprotection and Neuroplasticity, together with the Romanian Society of Neurology and “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania. It was endorsed by the World Federation of Neurorehabilitation (WFNR), the European Federation of Neurorehabilitation Societies (EFNR) and the EAN. -
by Amaia Muñoz Lopetegi I am truly satisfied with the fellowship experience, which has been absolutely enriching for my professional and personal development as a neurologist, both in the clinical side and in research. I am quite happy with… Continue Reading
-
Other News
BioMed Alliance – Moving forward from drug-centered to patient-centered clinical research
September 1, 2018The BioMed Alliance through the work of its Task Force “Clinical Trials” published a statement on the need for Europe to implement patient-centered clinical research.Precision medicine approaches the treatment of disease via an individual’s genes, environment, and… Continue Reading
-
by Anna Sauerbier European Brain Council provides feedback on the Horizon Europe proposals http://www.braincouncil.eu/activities/news/ebc-provides-feedback-on-the-horizon-europe-proposals/ The FDA designates device aiming to mitigate symptoms of agitation and depression associated with AD as… Continue Reading
-
Executive PageEAN NewsFeatured Slider
Executive Page: American Dream 2018: Report of a Sleep Researcher
September 1, 2018In 2 weeks, my sabbatical period in the United States, which started in April 2018, will come to an end. The word sabbatical comes from “Sabbath,” which in the biblical Old Testament was described as, “In the seventh year the land shall have a Sabbath of complete rest …” Today in Academics, it is obviously not simply rest. For me it was a break after 23 years of an uninterrupted hospital and university activity, 17 of which as chair or vice-chair of large neurological departments. -
EAN NewsCountry of the MonthTop ArticlesFeatured Slider
Country of the month – Azerbaijan
September 1, 2018This is the Land of Fire and the Pearl of the Caucasus, a land where eastern colors combine magnificently with western progress. Azerbaijan is situated at the eastern side of the Transcaucasia on the shores of the Caspian Sea. The… Continue Reading -
Paper of the MonthEAN NewsFeatured Slider
Paper of the month: Apomorphine pump is effective for motor fluctuations in Parkinson’s disease
September 1, 2018For September 2018, we have selected: Katzenschlager R, Poewe W, Rascol O, et al. Apomorphine subcutaneous infusion in patients with Parkinson’s disease with persisten motor fluctuations (TOLEDO): a multicenter, double-blind, randomized, placebo-controlled trial. Lancet Neurol July 25, 2018. doi:10.1016/S1474-4422(18)30284-4. Subcutaneous infusion of apomorphine, a potent dopamine receptor agonist, is widely used in patients with Parkinson’s disease (PD) with motor fluctuations not optimally controlled with oral medication, but the previous evidence base to support this approach was weak, derived from open label studies. -
Education cornerEducationTop Articles
13th international Summer School of Neurology
September 1, 20182-5 JULY 2018, EFORIE NORD, ROMANIA As it is tradition, the 2018 edition of the International Summer School of Neurology was held in the resort on the Black Sea coast, Eforie Nord, Romania. -
Manel Ben Hmidene Ep Tezeghdenti, Ben Arous, Tunisia Term of the stay: 6 weeks
-
Education cornerEducation
Get involved in EAN Education: Question writers/reviewers sought
August 6, 2018Are you already skilled at, or interested in learning how to review and write good Single Best Answer (SBA, multiple choice) questions? The EAN Education committee is seeking expressions of interest from anyone in the European neurology community to support… Continue Reading